Y. enterocolitica |
Infected mur. macrophages |
|
ROS |
237 |
|
|
Akt signaling, mcp1 mRNA, PI3K signaling? |
196 |
|
+ zymosan |
|
no inhibition of ROS? |
238 |
|
Infected + CD3/CD28-stim. hum. T-cells |
|
IL-2 secretion, proliferation |
196 |
|
Infected hum. neutrophils + opsonized zymosan |
|
ROS |
239 |
|
Infected hum. granulocytes + fMLP or PMA |
|
Phagocytosis no inhibition of ROS |
240 |
|
Infected mur. DCs |
|
Phagocytosis |
175 |
|
Y. pseudotuberculosis |
Infected hum.epithelial cells |
|
IL-8 secretion |
241 |
|
p-p130cas, pFAK, pFyb, pPaxillin, focal adhesion complexes |
Phagocytosis |
173,242,243,244,245,246 |
|
Infected mur. macrophages |
p-p130cas, pFyb focal adhesion complexes, SKAP-HOM?, no binding to FAK
|
|
173,246,247,248,249 |
|
+ opsonized bacteria |
|
ROS |
250 |
|
Phagocytosis |
251 |
|
Infected + TCR-stim. mur. T-cells |
|
IL-2 secretion |
252 |
|
Calcium flux, PI3K activity |
200 |
|
Infected + PMA- or ionomycin-stim. mur. T-cells |
|
No effect on IL-2 secretion |
252 |
|
Infected + TCR-stim. hum. T-cells |
pSLP-76, pLAT, not pLCK
|
Calcium flux, PI3K activity |
200 |
|
Infected, Ag-activated mur. B-cells |
|
B7.2 surface presentation |
252 |
|
Infected mur. neutrophils |
pSKAP-HOM?, pSLP-76?, pPRAM-1? (Fyb homolog), not Fyb
|
SLP-76 signaling, calcium flux, IL-10 mRNA, TNFα mRNA |
253 |
|
Infected mur. DCs |
|
No influence on phagocytosis |
176 |
|
Y. pestis |
Transfected hum. epithelial cells co-transfected with target proteins, pervanadate stim. |
|
Intrinsic apoptosis pathway |
177 |
p-p85 (PI3K subunit), pFyb, pLCK, Vav, Gab1, Gab2 |
|
254 |
Transfected or CPP-YopH treated hum. T-cells |
|
Intrinsic apoptosis pathway |
177 |
CPP-YopH treated, CD3/CD28- stim. hum. T-cells |
pLCK (Y394) |
IL-2 secretion |
172 |
Transfected, CD3/CD28- stim. hum. T-cells |
pLCK (Y394), pERK?, pZAP70?, pζ? |
NF-κB & NFAT/AP-1 signaling, IL-2 secretion |
172,233,254 |
Transfected or CPP-YopH treated, Ag-stim. rat mast cells |
|
Degranulation |
255 |